These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

13713 related articles for article (PubMed ID: 10530611)

  • 1. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93.
    Bulliard JL; Cox B; Semenciw R
    Cancer Causes Control; 1999 Oct; 10(5):407-16. PubMed ID: 10530611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993.
    Bulliard JL; Cox B
    Int J Epidemiol; 2000 Jun; 29(3):416-23. PubMed ID: 10869312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population?
    Dal H; Boldemann C; Lindelöf B
    Eur J Dermatol; 2007; 17(5):428-34. PubMed ID: 17673388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.
    Chen YT; Zheng T; Holford TR; Berwick M; Dubrow R
    Cancer Causes Control; 1994 Jul; 5(4):341-50. PubMed ID: 8080946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the site distribution of melanoma in New Zealand and Canada.
    Bulliard JL; Cox B; Elwood JM
    Int J Cancer; 1997 Jul; 72(2):231-5. PubMed ID: 9219825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand.
    Bulliard JL
    Int J Cancer; 2000 Mar; 85(5):627-32. PubMed ID: 10699940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
    Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
    J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984.
    Thörn M; Bergström R; Adami HO; Ringborg U
    Am J Epidemiol; 1990 Dec; 132(6):1066-77. PubMed ID: 2260538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: the increasing trend is broken.
    Karlsson PM; Fredrikson M
    Int J Cancer; 2007 Jul; 121(2):323-8. PubMed ID: 17372908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous melanoma.
    Armstrong BK; Kricker A
    Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site distribution of malignant melanoma.
    Elwood JM; Gallagher RP
    Can Med Assoc J; 1983 Jun; 128(12):1400-4. PubMed ID: 6850466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996.
    Marrett LD; Nguyen HL; Armstrong BK
    Int J Cancer; 2001 May; 92(3):457-62. PubMed ID: 11291086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site distribution of cutaneous melanoma in Queensland.
    Green A; MacLennan R; Youl P; Martin N
    Int J Cancer; 1993 Jan; 53(2):232-6. PubMed ID: 8425760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982-2001.
    Whiteman DC; Bray CA; Siskind V; Hole D; MacKie RM; Green AC
    Cancer Causes Control; 2007 Jun; 18(5):485-91. PubMed ID: 17450418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure.
    Elwood JM; Gallagher RP
    Int J Cancer; 1998 Oct; 78(3):276-80. PubMed ID: 9766557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008.
    Robsahm TE; Bergva G; Hestvik UE; Møller B
    Melanoma Res; 2013 Feb; 23(1):70-8. PubMed ID: 23222548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Garbe C; Orfanos CE
    Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increases in invasive melanoma in England, 1979-2006, by anatomical site.
    Wallingford SC; Alston RD; Birch JM; Green AC
    Br J Dermatol; 2011 Oct; 165(4):859-64. PubMed ID: 21623751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma in Connecticut and Denmark.
    Houghton A; Flannery J; Viola MV
    Int J Cancer; 1980 Jan; 25(1):95-104. PubMed ID: 7399748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Sex-Specific Incidence of Melanoma.
    Olsen CM; Thompson JF; Pandeya N; Whiteman DC
    JAMA Dermatol; 2020 May; 156(5):553-560. PubMed ID: 32211827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 686.